HIVE Digital Technologies Ltd. [NASDAQ: HIVE] gained 7.47% on the last trading session, reaching $3.31 price per share at the time.
If compared to the average trading volume of 4.16M shares, HIVE reached a trading volume of 3009554 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Here is what top equities market gurus are saying about HIVE Digital Technologies Ltd. [HIVE]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HIVE shares is $5.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HIVE stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for HIVE Digital Technologies Ltd. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 15, 2024. While these analysts kept the previous recommendation, B. Riley Securities raised their target price to Buy. The new note on the price target was released on July 19, 2024, representing the official price target for HIVE Digital Technologies Ltd. stock.
The Average True Range (ATR) for HIVE Digital Technologies Ltd. is set at 0.28, with the Price to Sales ratio for HIVE stock in the period of the last 12 months amounting to 2.81. The Price to Book ratio for the last quarter was 1.42, with the Price to Cash per share for the same quarter was set at 1.86.
Trading performance analysis for HIVE stock
HIVE Digital Technologies Ltd. [HIVE] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 17.79. With this latest performance, HIVE shares dropped by -23.02% in over the last four-week period, additionally sinking by -18.87% over the last 6 months – not to mention a drop of -7.28% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HIVE stock in for the last two-week period is set at 53.36, with the RSI for the last a single of trading hit 58.90, and the three-weeks RSI is set at 51.90 for HIVE Digital Technologies Ltd. [HIVE]. The present Moving Average for the last 50 days of trading for this stock 3.31, while it was recorded at 3.08 for the last single week of trading, and 3.31 for the last 200 days.
HIVE Digital Technologies Ltd. [HIVE]: A deeper dive into fundamental analysis
HIVE Digital Technologies Ltd.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.35 and a Current Ratio set at 7.35.
HIVE Digital Technologies Ltd. [HIVE]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, HIVE Digital Technologies Ltd. posted -0.29/share EPS, while the average EPS was predicted by analysts to be reported at -0.19/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.1. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HIVE.
An analysis of Institutional ownership at HIVE Digital Technologies Ltd. [HIVE]
There are presently around $29.74%, or 29.86%% of HIVE stock, in the hands of institutional investors.
